Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Raunhild Butzer"'
Autor:
Christian Hausdorf, Kerstin Breithaupt-Grögler, Winfried Fuchs, Gustav G Belz, Christian Mang, Raunhild Butzer
Publikováno v:
Journal of the Renin-Angiotensin-Aldosterone System, Vol 1 (2000)
Rationale A quantitative technique was used to compare the pharmacological potency in healthy volunteers of angiotensin II receptor antagonists (AIIA): candesartan cilexetil, losartan, irbesartan, valsartan, and telmisartan. Methods In a randomised,
Publikováno v:
Clinical Pharmacology & Therapeutics. 66:367-373
Objective To compare the angiotensin II antagonistic properties of the usual recommended oral starting doses of various angiotensin II receptor antagonists—150 mg irbesartan, 80 mg valsartan, and 50 mg losartan—in humans. Subjects And Methods Eig
Autor:
Susanna Roll, Steffen G. Magin, Gustav G Belz, Claudius Malerczyk, Kerstin Breithaupt-Grögler, Ernst Mutschler, Anette Högemann, Barbara Voith, Bettina Fuchs, Volker Herrmann, Raunhild Butzer
Publikováno v:
British Journal of Clinical Pharmacology. 45:567-573
Aims The pharmacodynamic properties of the angiotensin II antagonist candesartan in humans were assessed from the rightward shifts of angiotensin II dose-effect curves (Schild regression technique). The pharmacokinetic characteristics were determined
Publikováno v:
British Journal of Clinical Pharmacology. 34:88-92
The reproducibility and agreement of the estimates of stroke volume (SV), cardiac output (CO) and total peripheral resistance (TPR) by transthoracic impedance cardiography (ZCG) and M-mode echocardiography (ECHO) were analyzed before and after the pl
Publikováno v:
Paediatric drugs. 11(1)
Clinical trials in children are mandatory to generate data on new drugs as well as on drugs used off-label or for unlicensed indications. The EU Paediatric Regulation introduced in 2007 provides the background, goals, and requirements for pediatric c
Publikováno v:
The Journal of Maternal-Fetal & Neonatal Medicine. 26:544-545
Letter to the EditorWe read with interest the study by Moreira et al. on the impact of providing vitamin A to the routine pulmonary care of extremely low-birth weight infants (ELBW) [1]. In their r...
Publikováno v:
Journal of cardiovascular pharmacology. 39(4)
Summary: The in vivo effects of two unsurmountable angiotensin II type 1 (AT1) antagonists, irbesartan (150 mg) and candesartan (8 mg), were studied in a double-blind, randomized, crossover study in 18 healthy men. The drugs' direct vascular effects
Autor:
V Schroeter, Gustav G Belz, Nixdorff U, Helge Simon, Jürgen Meyer, Raimund Erbel, Raunhild Butzer, Christian de Mey
Publikováno v:
Journal of cardiovascular pharmacology. 29(4)
To determine the effects of beta-adrenergic stimulation on transmitral Doppler echocardiography flow characteristics of left ventricular diastolic filling, we studied 10 healthy volunteers aged 23-31 years (mean age, 26.6 years) during intravenous in
Publikováno v:
British journal of clinical pharmacology. 40(4)
1. The agreement of blood pressure measurements by stethoscope auscultation (SBPa, DBPa-IV and DBPa-V), oscillometry (Dinamap; SBPo, and DBPo) and digital photoplethysmography (Finapres; SBPf, and DBPf) with the graphical analysis of the analogue mic
Autor:
Christian de Mey, Jürgen Meyer, V Schroeter, G. G. Belz, Raimund Erbel, Raunhild Butzer, Uwe Nixdorf
Publikováno v:
Clinical pharmacology and therapeutics. 52(6)
Study objective The study was performed to evaluate the relative sensitivity of various noninvasive methods to detect and describe the systolic cardiovascular effects of stepwise increasing doses of isoproterenol: two-dimensional left ventricular ech